NCT00469469View on ClinicalTrials.gov

Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma

PHASE2WithdrawnINTERVENTIONAL

0

Timeline

Start Date

May 31, 2007

Study Completion Date

September 30, 2009

Conditions

Adrenocortical Carcinoma

Interventions

DRUG

Bevacizumab

Trial Locations (1)

03756

Dartmouth-Hitchcock Medical Center, Lebanon

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT00469469 - Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma | Biotech Hunter | Biotech Hunter